Buscar
Mostrando ítems 11-20 de 324
Revascularización del vaso culpable versus completa en enfermedad de múltiples vasos en infarto agudo de miocardio con elevación del segmento ST. Metaanálisis de ensayos clínicosCulprit vessel revascularization versus complete revascularization in multivessel disease in acute myocardial infarction with st-segment elevation. Meta-analysis of clinical trials
(Asociación Colombiana de Medicina InternaGrupo para el Estudio de las Enfermedades CardiovascularesBogotá, Colombia, 2021)
El rol de la resonancia magnética cardíaca en el diagnóstico diferencial entre miocarditis aguda e infarto agudo de miocardio con elevación del segmento ST
(Sociedad Médica De Santiago, 2021)
Background: Acute myocarditis frequently mimics an acute myocardial infarction, and its diagnosis is a clinical challenge. Aim: To describe the characteristics of cardiac magnetic resonance imaging in patients with acute ...
Adjunctive Thrombectomy in Primary Percutaneous Intervention for Acute Myocardial Infarction
(Arquivos Brasileiros CardiologiaRio De JaneiroBrasil, 2011)
Association of the use of manual thrombus aspiration with intracoronary thrombotic burden in patients with ST segment elevation myocardial infarction in the real world
Introduction: Although the routine use of manual thrombus aspiration (MTA) in patients with ST-elevation myocardial infarction (STEMI) provides no benefit compared to conventional primary percutaneous coronary intervention ...
In-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy Mortalidad intrahospitalaria en hombres y mujeres según terapias de reperfusión en infarto agudo del miocardio con supradesnivel del ST
(Sociedad Medica de Santiago, 2008)
Background: Primary angioplasty is considered the best reperfusion therapy in the treatment of ST-segment elevation myocardial infarction (STEMI). However, thrombolysis is the reperfusion method most commonly used, due to ...
Effect of pharmacological treatment on cardiac biomarkers in patients with acute coronary syndrome of non–ST segment elevation with Type-2 diabetes
(IJMHS, 2016-01)
The acute coronary syndrome is a consequence of coronary artery disease. Creatine Kinase MB is a cardiac biochemical marker used in the diagnosis and risk stratification of patients. The diabetes is a pathology associated ...
Modification of cardiac biomarkers sensity in hypertensive patiens treated with angiotensin-converting enzyme inhibitors in acute coronary syndrome with non-st segment elevation
(International Knowledge Press, 2019-06)
Background: Patients with non-ST segment elevation myocardial infarction and the mortality risk is associated when Creatine Kinase isoenzyme MB and Troponin I values are increase. Objective: The present study was oriented ...
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial
(American Medical Association, 2018)
Importance: The bleeding safety of ticagrelor in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy remains uncertain. Objective: To evaluate the short-term safety of ticagrelor when compared ...
Fondaparinux em intervenção coronária percutânea no tratamento da síndrome coronária aguda
(2012-06-01)
Background: Fondaparinux is considered an agent with a well-established safety and efficacy profile in the treatment of non-ST segment elevation acute coronary syndromes, but when used alone, is associated to a higher ...